Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Rubicon Genomics Ink Supply Agreement for Amplification Kits

NEW YORK (GenomeWeb) – Rubicon Genomics announced today that it has signed a supply agreement with Agilent Technologies for Rubicon's PicoPlex WGA kits. 

The kits, which can be used in microarray analyses as well as in PCR assays, will be sold with Agilent's GenetiSure Pre-Screen kit, which is used for comprehensive genome-wide analysis of embryos, including aneuploidy analysis of all 24 chromosomes. 

PicoPlex WGA single-tube protocol kits are designed to amplify genomic DNA from a single cell. The technology can also be used to genetically characterize any single cell sample or picogram quantities of isolated DNA, Rubicon said.

"Our patented PicoPlex WGA kits have a well-earned reputation for quality and reproducibility in the assisted reproduction field, where they have been a key component in pre-implantation genetic screening," Rubicon CEO James Koziarz said in a statement. "We're delighted that Agilent will be making our kits available to their customers."

Further terms of the agreement were not disclosed.

Rubicon announced earlier this month that it has been acquired by Takara Bio USA Holdings